Oesophageal cancer is the sixth most common cause of cancer-related death worldwide
and is therefore a major global health challenge. The two major subtypes of oesophageal …

These recommendations provide an evidence-based approach to the role of esophageal
stents in the management of benign and malignant diseases. These guidelines have been …

Cancers originating in the esophagus or esophagogastric junction constitute a major global
health problem. Esophageal cancers are histologically classified as squamous cell …

The primary objective of these guidelines is to provide general clinicians with information
that would guide them to make informed choices of the available diagnosis/treatment …

Oesophageal cancer is the 19th most common cancer in the European Union (EU), with∼
45 900 new cases diagnosed in 2012 (1% of the total). In the EU, the highest age …

This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy
(ESGE), endorsed by the European Society for Radiotherapy and Oncology (ESTRO), the …

Malignant disease 1 ESGE recommends placement of partially or fully covered self-
expandable metal stents (SEMSs) for palliation of malignant dysphagia over laser therapy …

Applications of prediction models | SpringerLink Skip to main content Advertisement
SpringerLink Account Menu Find a journal Publish with us Track your research Search Cart …

Adequate reporting of randomized, controlled trials (RCTs) is necessary to allow accurate
critical appraisal of the validity and applicability of the results. The CONSORT (Consolidated …

BACKGROUND: Both gastrojejunostomy (GJJ) and stent placement are commonly used
palliative treatments of obstructive symptoms caused by malignant gastric outlet obstruction …